ABSTRACT Prepubertal gilts of control ( n = 301, obese ( n = 30), or lean ( n = 29) genetic lines were implanted with no, one, or two implants of porcine somatotropin (pST, each delivers 2 mg/d) for 6 wk starting at 160 d of age to determine whether pST affects ovarian function. At 4 mg/d, pST increased ( P < .01) numbers of 4.0-to 6.9-mm (medium) follicles but not ( P > .lo) numbers of 1.0-to 3.9-mm (small) follicles per gilt. Both doses of pST increased ( P < .01) serum and follicular fluid ( F F L ) concentrations of IGF-I and activity of IGF binding protein (IGFBPI-3 and 36-kDa IGFBP in all three lines; IGFBP-3 was the predominant IGFBP. In comparison, binding activity of IGFBP-2 was decreased ( P c .O 1) in serum by 4 mg of pST but increased ( P c .05) in FFL by 4 mg of pST. Lean gilts had lower ( P < .05) serum concentrations of IGF-I and less ( P c .05) total binding activity of IGFBP than control and obese gilts. Concentrations of estradiol in FFL of small and medium follicles tended ( P < .OS) to be increased by 2 mg/d of pST, whereas FFL concentrations of progesterone were unaffected by pST. Obese and control gilts had twofold greater ( P c . 0 5 ) FFL progesterone concentrations than lean gilts. We conclude that sustained-release implants of pST can stimulate follicular growth, increase concentrations of IGF-I in serum and FFL, and increase IGFBP activity in serum of genetically divergent lines of gilts without an adverse effect on ovarian function.
Introduction
Recent attempts to improve production efficiency in domestic pigs has concentrated on the use of exogenous porcine somatotropin ( pST) supplied in slowrelease implants (Azain et al., 1992; Klindt et al., 1992a; Hacker et al., 1993) . Long-term pST treatment supplied in daily injections has stimulatory and inhibitory effects on reproductive functions in gilts J. h i m . Sci. 1994 . 72:2431 -2440 (Bryan et al., 1989 Kirkwood et al., 1989; Spicer et al., 1992) . Some of these reproductive responses to pST are affected by genotype of the gilts (Spicer et al., 1992) . However, the effect of sustained-release implants of pST on reproductive functions in gilts has not been reported. The ovarian effect of ST is thought to be mediated through direct effects of ST on ovarian follicles (Hsu and Hammond, 1987; Mondschein et al., 1989; Langhout et al., 1991) , and, in part, through increased hepatic production of IGF-I (Gluckman et al., 1987; Guidice, 1992) . Although ST is thought to play an important role in the onset of puberty in female rats (Ramaley and Phares, 19801 , daily injections of pST starting at 3 to 4 mo of age did not alter the age of puberty onset in gilts (Andres et al., 1991; Terlouw et al., 1991) . Our experiment was designed to determine whether sustained-release implants of pST affect ovarian follicular function in prepubertal gilts from populations selected for either high (obese) or low (lean) backfat, and a control population.
Materials and Methods

Animals and Treatments.
Gilts from a contemporary line (control, n = 30) and from lines selected for high (obese, n = 30) or low (lean, n = 29) backfat were implanted for 6 wk with no, one, or two implants that deliver 0, 2, or 4 mg of recombinant pST per day, respectively, starting at approximately 160 d of age (59.0 k 1.4 kg of BW). The control gilts were unselected 1/4 Landrace-1/4 Yorkshire-1/4 Chester White-1/4 Large White gilts. The obese and lean pigs were Duroc obese x Yorkshire obese and Duroc lean x Yorkshire lean pigs derived from populations selected solely for high or low backfat thickness over multiple generations (Hetzer and Harvey, 1967) . The gilts were allotted into four replicates to be slaughtered on four different days between May 15 and July 2, 1991. Gilts were fed, to appetite, a diet composed of 64.5% corn and 31.6% soybean meal (19.5% CP; as-fed basis), supplemented with dicalcium phosphate, ground limestone, trace mineral premix, and vitamin premix (2.4, .5, .2, and .2% as-fed basis, respectively). The contents of the trace mineral premix and vitamin premix have been described previously (Yen et al., 1990) . Calculated lysine concentration of the diet was 1.08% (as-fed basis).
Gilts were slaughtered approximately 6 wk (41.4 & .1 d ) after the implantation of pST. Ovaries and uteri were removed and weighed at slaughter, and the numbers of all follicles 2 1 mm on the ovarian surface were recorded. The follicular fluid (FFL) from follicles 1 to 3.9 mm (small) and 4 to 6.9 mm (medium) in diameter was collected and pooled within each size group and ovary. Fluid from large ( 2 7.0 mm) follicles was also collected, but very few of these large follicles were found and therefore this FFL was not analyzed. Blood samples were collected at slaughter for IGF-I analysis. Serum and FFL were stored at -20°C until they were analyzed.
Radioimmunoassays. Immunoreactive IGF-I in FFL
and serum was determined with RIA after acidethanol extraction as described previously Echternkamp et al., 1990) . This procedure resulted in parallelism between human IGF-I standard (Amgen Biologicals, Thousand Oaks, CAI and porcine FFL and serum. Intra-and interassay CV were 12.0 and 14.3%, respectively. Concentrations of progesterone in FFL were quantified with a RIA (Baranao and Hammond, 1985) . Intra-and interassay CV were 9.9 and 16.1%, respectively. Concentrations of estradiol in FFL were quantified with a RIA (Cox et al., 1987) as modified by Spicer and Enright ( 199 1) . This procedure resulted in parallelism between estradiol standard and porcine FFL. Intra-and interassay CV were 15.4 and 27.9%, respectively.
Insulin-Like Growth Factor I Binding Protein Activity. Total IGFBP activity in serum was determined after incubation with [1251]IGF-I by the method of Moses et al. (1979) . Samples of FFL from small or medium follicles were pooled within gilt before analysis. Briefly, 10-pL aliquots of serum or FFL were incubated overnight at 4°C with 100 pL of [125111GF-I (15,000 cpm; counter efficiency was 75%) and 150 pL of assay buffer (PBS containing 2.5 mg of BSMmL, pH = 7.5). To separate bound from free [125111GF-I, activated charcoal (500 pL; 5% wt/vol in PBS containing 2.5 mg of BSA/mL) was added to each tube, incubated for 30 min at 4"C, and centrifuged at 1,200 x g for 20 min at 4°C. Intra-and interassay CV were 7.9 and 17.4%, respectively.
To evaluate the various molecular weight species of the IGFBP, one-dimensional SDS-PAGE was performed on serum and representative follicular fluid samples under nonreducing conditions as described previously for porcine FFL (Howard and Ford, 1992 Statistical Analyses. Hormone data within each treatment were grouped into two follicle-size groups, based on diameter of follicle: 1.0 to 3.9 mm (small) and 4.0 to 6.9 mm (medium). Follicle data were analyzed with least squares ANOVA (SAS, 1988) for a 3 x 3 x 2 factorial arrangement in a randomized design. Main effects were dose of pST = 0, 2, or 4; line = control, obese, or lean; follicle size = small or medium. Data on the various molecular weight forms of IGFBP in serum and FFL were analyzed with least squares ANOVA for a 3 x 3 x 3 factorial arrangement in a randomized design; main effects were as follows: dose of pST = 0, 2, or 4; line = control, obese, or lean; source = serum, small FFL, or medium FFL. Serum IGF-I was analyzed as a 3 x 3 factorial ANOVA. All possible interactions were also evaluated. Data with heterogeneous variances (FFL progesterone and estradiol) were analyzed after transformation to In ( x + 1). Specific differences between means were determined using the PDIFF procedure (SAS, 1988 ) if significant main effects were detected. Relationships among selected variables were evaluated with regression and simple correlation analyses (Pearson correlation coefficients; SAS, 1988).
Results
Gross Ovarian and Uterine Morphology. As assessed by the absence of any corpora lutea, all gilts were prepubertal at slaughter. Ovarian weight was influenced by pST ( P < . 0 5 ) and line ( P < .OO 1) but not by the pST x line interaction ( P > .20).
Specifically, ovarian weight was greater ( P < .05) in gilts treated with 4 mg of pST (6.20 t-.26 g ) than in gilts treated with 0 mg of pST (5.22 t-.25 g ) and intermediate in gilts treated with 2 mg of pST (5.77 & .25 g). Ovarian weight was greater ( P < .05) for control gilts than for lean or obese gilts (Table 1) . When ovarian weight was expressed as gramskilogram of BW at slaughter, it was not affected by pST ( P > .lo), because pST increased ( P < .05) BW proportionately. However, adjusted ovarian weight (gramskilogram BW) was affected ( P < .01) by line; control gilts had the greatest ovarian weight (.084 k .003 g/kg), lean gilts had the least ovarian weight (.059 -t .004 g/kg), and obese gilts had an intermediate ovarian weight (.068 t-.003 g/kg). Uterine weight was unaffected ( P > . l o ) by pST dose, line, or their interaction ( Table 1) .
Numbers of medium follicles were increased ( P < .01) 2.4-fold by 4 mg of pST (Figure l), whereas numbers of small follicles were unaffected ( P > .lo) by pST. Numbers of medium, but not small, follicles were also affected ( P < . l o ) by line; control gilts had 2.3-fold greater numbers of medium follicles than did lean or obese gilts (Figure 1 ). between lean and obese gilts was detected in gilts treated with 4 mg of pST (Table 1) . Porcine somatotropin also increased concentrations of IGF-I in FFL 3.8-and 4.5-fold for 2 and 4 mg of pST, respectively, relative to 0 mg of pST ( Figure 2 ). Significant main effects and interactions were dose of pST ( P < . O l ) , line ( P < .Ol), follicle size ( P < . O l ) , pST x line ( P < .O 1 l7 pST x follicle size ( P < .O 1 1, and line x follicle size ( P < .05); the three-way interaction was not significant ( P > .lo). In FFL of small, but not medium, follicles (pST x follicle size, P < . O l ) , IGF-I concentrations were further increased by 4 mg of pST (i.e., vs 2 mg of pST, 187 vs 137 ng/mL, SEM = 11, P < However, line and follicle size affected ( P < .01) FFL progesterone concentrations ( Figure 3 ). All interactions were nonsignificant ( P > .lo). Concentrations of progesterone were twofold greater in obese and control gilts than in lean gilts, and were 25% greater in small vs medium follicles (Figure 3 ).
Insulin-Like Growth Factor I in Serum and
Concentrations of estradiol in FFL were influenced by line ( P < .05) and follicle size ( P < .001); none of the interactions influenced ( P > .20) FFL estradiol concentrations. Obese gilts had 1.9-fold greater FFL estradiol concentrations than control and lean gilts (8.4 vs 4.6 and 4.3 ng/mL, SEM = 1.5, respectively), and medium follicles had 2.3-fold greater concentrations of estradiol than small follicles (8.1 vs 3.5, SEM = 1.2 ng/mL). Dose of pST tended ( P < .OS) to influence FFL estradiol concentrations; estradiol concentrations were increased in medium follicles of control and obese gilts by 2 mg of pST only (Figure 4) . (Table 1) . Treatment with 2 and 4 mg of pST, relative to 0 mg, increased ( P < .05) IGFBP activity in serum 1.7-and 2.0-fold, respectively. Lean gilts had less ( P < .05) IGFBP activity in serum (7.1 k .4%) than did control (9.1 k .4%) or obese (8.9 k .4%) gilts. Serum IGFBP activity correlated positively ( P < .05) with serum IGF-I in control, lean, and obese gilts ( r = .71, .76, and .46, respectively).
Ligand Blot Analysis of Insulin-Like Growth Factor I Binding Protein in Follicular Fluid and Serum.
Ligand blots revealed that at least six forms of IGFBP activity existed in porcine FFL and serum (Figure 5 ) . Two major bands of IGFBP (40 and 44 kDa) were identified as doublets of IGFBP-3 and combined for analysis. The 34-kDa IGFBP was identified as IGFBP-2. The amount of binding activity for IGFBP-2 and for the 36-and 22-kDa IGFBP was affected ( P < .01) by fluid source (Table 2 ). Specifically, serum had less IGFBP-2 and 36-kDa IGFBP activity and more 22-kDa IGFBP activity than FFL. Both 2 and 4 mg of pST increased ( P < 
Discussion
Treatment of pigs with daily injections of pST or sustained-release implants of pST has caused 2-to 11-fold increases in serum IGF-I concentrations in previous studies (Evock et al., 1988; Bryan et al., 1989 Bryan et al., , 1992 Klindt et al., 1992a; Spicer et al., 1992) . Similarly, we measured two-to fivefold increases in serum IGF-I in blood of gilts treated with sustainedrelease implants that delivered 2 or 4 mg of pST daily. This increase in serum IGF-I, and the associated increases in pST, IGF-11, and(or) insulin (Klindt et al., 1992b) , may account for the increases in ovarian weight and follicular function (Geisthovel et al., 1990; Guidice, 1992) and for the changes in growth performance and carcass measurements (Buonomo et al., 1992) of pST-treated pigs.
The mechanism by which pST alters follicular growth is unknown. Presumably the increased number of medium follicles in pST-treated gilts resulted from increased IGF-I concentrations in serum and(or) FFL, because IGF-I stimulates granulosa cell mitosis in vitro (Geisthovel et al., 1990; Guidice, 1992) . In with different letters differ (P < .05).
support of this suggestion, we found that FFL IGF-I concentrations and number of medium, but not small, follicles were correlated positively ( r = .41 in obese and r = .55 in lean gilts). Previously, a positive association ( r = .3 to . 5 ) between numbers of small ovarian follicles and FFL IGF-I was detected in lean and obese gilts treated with daily injections of pST for 6 wk (Spicer et al., 1992) . Similarly, Gong et al. ( 199 1) observed that daily injections of bST for 42 d in postpubertal heifers increased the number of small ( 2 to 5 mm), but not medium or large, follicles. It is unclear why numbers of medium follicles and not small follicles were affected by pST in the present vs previous study, but it may be due in part to the difference in the delivery system of pST (implant vs injection).
In vitro, IGF-I stimulates estrogen production by granulosa cells from rats (Davoren et al., 1986) , pigs (Maruo et al., 1988) , humans (Erickson et al., 1990) , and cattle (Spicer et al., 19931 . Consistent with these in vitro findings, estradiol concentrations in the present study were greater in FFL of cqntrol and obese gilts treated with 2 mg of pST daily than in that of untreated control and obese gilts; these changes in FFL estradiol were coincident with fourfold increases in IGF-I concentrations in serum and FFL. In addition, estradiol and IGF-I concentrations in FFL of control and lean gilts were lower than in FFL of obese gilts. In comparison, Bryan et al. (1989 Bryan et al. ( , 1992 found no effect of daily injections of pST on FFL estradiol concentrations in Yorkshire or Duroc gilts, whereas Spicer et al. (1992) found that daily injections of pST had a significant inhibitory effect on FFL estradiol concentrations of obese gilts. Similar to gilts treated with daily pST injections, transgenic prepubertal gilts expressing the bST gene had significantly lower estradiol concentrations in FFL of large, but not medium, follicles than control gilts 3 d after PMSG treatment (Guthrie et al., 1993) . The reasons for the discrepancies between the present and prior studies are unknown but may include differences in pSTand(or) IGF-I-mediated effects on granulosa cell cytodifferentiation (e.g., expression of gonadotropin receptors). Spicer et al. (1992) reported a decrease in the numbers of LWhCG binding sites in granulosa cells of medium follicles collected from prepuberal gilts receiving daily injections of pST. In vitro, ST has no effect on FSH-induced estrogen production by rat granulosa cells (Jia et al., 1986) or on basal estradiol production by porcine granulosa cells (Nitray et al., 1993) . Thus, it is unlikely that increased pST directly caused the increase in FFL estradiol concentrations observed in the present study, and that differences in pST concentrations achieved with daily injections vs sustained-release implants of pST account for differences in the effect of pST on FFL estradiol concentrations among studies. Perhaps the greater IGF-I concentrations in transgenic gilts or after daily pST injections vs pST implants caused a down-regulation of the ovarian IGF-I system. Previous research has shown that high IGF-I concentrations can cause postreceptor desensitization (Cascieri et al., 1988) . However, further research with pigs will be required to verify these suggestions.
In vitro, ST and IGF-I enhance progesterone production by cultured porcine granulosa cells (Baranao and Hammond, 1984; Veldhuis et al., 1985; Hsu and Hammond, 1987; Kirkwood et al., 1992) . These effects seem to be direct because both ST and IGF-I receptors are present in granulosa cells (Carlsson et al., 1992; Guidice, 1992) . Also, pST treatment in vivo enhanced subsequent in vitro progesterone production by porcine granulosa cells stimulated by LH but had no effect on basal or FSH-stimulated progesterone production (Bryan et al., 1991) . In contrast to in vitro Walues are pooled means of control. lean, and obese lines.
bEffect of pST ( P < ,001). CEffect of fluid source ( P < ,001).
dEffect of pST ( P < .05).
studies, pST treatment in vivo has little or no effect on FFL progesterone concentrations (Bryan et al., 1989 (Bryan et al., , 1992 Spicer et al., 1992 ; present study). The reasons for the discrepancies between in vitro and in vivo studies are unknown. Similar t o previous reports (Buonomo et al., 1987; Walton and Etherton, 1989; Evock et al., 1990; Owens et al., 1990; Spicer et al., 19921 , pST increased total IGFBP and IGFBP-3 activity in serum of gilts in the present study. We also found that pST decreased IGFBP-2 activity in serum. Similarly, Klindt et al. (1992a) showed that serum IGFBP-2 concentrations decreased after 7 to 42 d of 2 or 4 mg of pSTId in pigs. Although total IGFBP activity (measured by charcoal exchange and by ligand blotting) in FFL was increased 1.4-to 2.0-fold by pST, amounts of the various molecular weight species of IGF-binding proteins in FFL were not affected similarly by pST treatment. Specifically, FFL IGFBP-3 was increased by pST, whereas FFL IGFBP-2 was unaffected. Two of the three lower-molecular-weight IGFBP in FFL were also increased by pST. Others have found similar numbers and sizes of IGFBP in FFL of weaned sows (Howard and Ford, 1992) and pools of FFL from abattoir porcine ovaries , except for the 36-kDa IGFBP found in the present study.
Whether this 36-kDa IGFBP is a deglycosylated form of IGFBP-3 remains to be determined. Nonetheless, these IGFBP are thought to sequester IGF-I and inhibit its action on follicular function Guidice, 1992) , and thus, local actions of IGF-I may have been attenuated by the twofold increases in IGFBP induced by pST in the present study. However, total IGF-I concentrations in serum and FFL increased by three-to fivefold after pST treatment. Unfortunately, we do not know the effect of pST on biologically available IGF-I. Because the inhibitory effect of IGFBP on granulosa cell estradiol production is blocked in the presence of high (> 5 pM) concentrations of IGF-I (Vi et al., 19891 , the greater increase in IGF-I concentrations than in IGFBP activity with pST treatment may have "overridden" the inhibitory effects of IGFBP in the present study. Similarly, we do not know the effect of pST on the number and(or) binding affinity of IGF-I receptors on follicular cells. Therefore, whether the IGFBP actually inhibit follicular steroidogenesis may depend on the relative changes in concentrations of both IGF-I, IGF receptors, and IGFBP.
Similar to previous studies examining bovine (Spicer et al., 1988; Echternkamp et al., 1990; Spicer and Enright, 1991) and porcine follicles Spicer et al., 19921 , a positive association between follicle size and IGF-I concentration was detected. Whether this greater concentration of IGF-I in medium vs small follicles is due to increased local biosynthesis or increased diffusion of IGF-I from serum remains to be determined. Concentrations of IGF-I in serum and FFL were positively correlated in the present ( r = .60 to .77, P < .01) and a previous ( r = .81; Spicer et al., 1992) study, supporting the idea that blood serum is a source of intraovarian IGF-I. Regardless of the source of FFL IGF-I, the concentrations measured in FFL in the present study are close to the maximal concentrations that have been tested and shown to stimulate porcine granulosa cell proliferation and steroidogenesis in vitro (Baranao and Hammond, 1984; Veldhuis et al., 1985; Maruo et al., 1988; May et al., 1988) .
Implications
Long-term treatment of prepubertal gilts with porcine somatotropin delivered through a sustainedrelease implant increased numbers of medium ovarian follicles and tended to increase estradiol concentrations in medium follicles, an observation not previously found with daily injections of porcine somatotropin. The mediator(s) of the effects of porcine somatotropin on follicular function is(are) unknown but may be linked to its stimulation of the insulin-like growth factor system. Whether sustained-release implants of porcine somatotropin will increase follicular development and ovulation rate or improve reproductive performance in pubertal gilts and mature sows remains t o be determined. 
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